galt, not just ALS, but Parkinson's, Alzheimers, MS, and the DoD big concern, biochemical/bioterror agents, compare Galantamine. Iclusig is active against KIT and a few other related kinases that are relevant.
Key, Iclusig crosses the blood brain barrier in strength.
Long ago, jaybe published the post that linked to the patent Ariad filed for these apps. I'm hoping that Denner was thinking of these when he went off the reservation on partnering. These need to be partnered.
I did not want my letter on this to the BoD to get lost in the EMA decision, so I held off sending it until next week. It is written, and like others I have written to them, they will likely discuss.
Market Data 
Markets 
AI
